Aridis Pharmaceuticals Receives Funding To Evaluate Inhaled Monoclonal Antibodies To Block Influenza And Sars-Cov-2 Transmission
Round Type
Funding Round
Description
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, received a grant award from the Bill & Melinda Gates Foundation ('Gates Foundation') to evaluate the application of Aridis' inhaled formulation technology to deliver cost-effective monoclonal antibodies (mAbs) against influenza and SARS-CoV2 to people in low- and middle-income countries.
Quick answer
Aridis Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round, dated January 27, 2022. Aridis Pharmaceuticals, Inc. is based in Los Gatos, California, United States.
- How much did Aridis Pharmaceuticals, Inc. raise?
- Aridis Pharmaceuticals, Inc. raised an undisclosed amount in a Funding Round round on January 27, 2022.
- What does Aridis Pharmaceuticals, Inc. do?
- Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections.
- Where is Aridis Pharmaceuticals, Inc. based and how big is it?
- Aridis Pharmaceuticals, Inc. is based in Los Gatos, California, United States.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Aridis Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.
- CardioWise, Inc. raised $300K (Seed) on March 11, 2022.
- Seriously Clean LTD raised an undisclosed amount on March 11, 2022.
- Avive Solutions, Inc. raised $57M on March 11, 2022.
- Dragonfly Therapeutics, Inc. raised $13M on March 11, 2022.
- Vascarta Inc. raised $50K (Seed) on March 11, 2022.
- RefleXion Medical raised $80M (Funding Round) on March 10, 2022.
Who to call at Aridis Pharmaceuticals, Inc., and when
A new round usually means Aridis Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aridis Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aridis Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aridis Pharmaceuticals, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aridis Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Aridis Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.